A new allergen in the pharmaceutical industry. 2008

S Jungewelter, and K Aalto-Korte
Section of Dermatology, Finnish Institute of Occupational Health (FIOH), FI-00250 Helsinki, Finland. soile.jungewelter@ttl.fi

UI MeSH Term Description Entries
D008297 Male Males
D009783 Dermatitis, Occupational A recurrent contact dermatitis caused by substances found in the work place. Occupational Dermatitis,Dermatosis, Industrial,Industrial Dermatosis,Dermatitides, Occupational,Dermatoses, Industrial,Industrial Dermatoses,Occupational Dermatitides
D004345 Drug Industry That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function. Industries, Pharmaceutic,Industry, Drug,Industry, Pharmaceutic,Industry, Pharmaceutical,Pharmaceutical Industry,Drug Industries,Industries, Drug,Industries, Pharmaceutical,Pharmaceutic Industries,Pharmaceutic Industry,Pharmaceutical Industries
D005485 Flutamide An antiandrogen with about the same potency as cyproterone in rodent and canine species. Niftolid,Apimid,Apo-Flutamide,Chimax,Cytamid,Drogenil,Euflex,Eulexin,Eulexine,Fluken,Flulem,Flumid,Fluta 1A Pharma,Fluta-GRY,Fluta-cell,Flutamin,Flutandrona,Flutaplex,Flutexin,Fugerel,Grisetin,Niftolide,Novo-Flutamide,Oncosal,PMS-Flutamide,Prostacur,Prostica,Prostogenat,SCH-13521,Testotard,Apo Flutamide,ApoFlutamide,Fluta GRY,Fluta cell,FlutaGRY,Flutacell,Novo Flutamide,NovoFlutamide,PMS Flutamide,SCH 13521,SCH13521
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000485 Allergens Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). Allergen
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D016273 Occupational Exposure The exposure to potentially harmful chemical, physical, or biological agents that occurs as a result of one's occupation. Exposure, Occupational,Exposures, Occupational,Occupational Exposures

Related Publications

S Jungewelter, and K Aalto-Korte
July 2010, Allergy,
S Jungewelter, and K Aalto-Korte
February 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
S Jungewelter, and K Aalto-Korte
January 1985, The Journal of the Medical Society of New Jersey,
S Jungewelter, and K Aalto-Korte
January 2003, New Jersey medicine : the journal of the Medical Society of New Jersey,
S Jungewelter, and K Aalto-Korte
October 1968, Journal of the Irish Medical Association,
S Jungewelter, and K Aalto-Korte
May 2001, Clinical pharmacology and therapeutics,
S Jungewelter, and K Aalto-Korte
February 1998, PharmacoEconomics,
S Jungewelter, and K Aalto-Korte
February 2003, BMJ (Clinical research ed.),
S Jungewelter, and K Aalto-Korte
January 1990, Health affairs (Project Hope),
S Jungewelter, and K Aalto-Korte
January 1963, Proceedings of the Western Pharmacology Society,
Copied contents to your clipboard!